Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allozymes has developed a proprietary microfluidics-based platform that enables ultra-high-throughput screening and engineering of enzymes. The company partners with organizations across pharmaceuticals, life sciences & diagnostics, food & nutrition, chemicals, bioremediation/environmental cleanup, personal care/cosmetics—delivering custom biosolutions that are more sustainable than traditional methods. Recent partnerships include Adisseo for next-generation animal feed ingredient production using engineered enzymes for methionine synthesis. The company has raised over $20M in funding and continues expanding globally with new subsidiaries in Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allozymes.